Lannett Company, Inc.
Lannett Company, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1942, Lannett has established itself as a leader in the development, manufacturing, and distribution of generic pharmaceuticals, primarily focusing on oral solid dosage forms. With a strong operational presence across various regions, the company is dedicated to providing high-quality, affordable medications that meet the needs of patients and healthcare providers.
Lannett's core product offerings include a diverse range of generic drugs, which are distinguished by their rigorous quality standards and commitment to innovation. The company has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Recognised for its reliability and expertise, Lannett continues to strengthen its position in the competitive pharmaceutical landscape, making a meaningful impact on public health.
-20 vs industry average
Lannett Company, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Lannett Company, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Lannett Company, Inc. yet.
Lannett Company, Inc.'s reported carbon emissions
Lannett Company, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Lannett may not have established a comprehensive framework for addressing its carbon footprint or climate impact at this time. As the pharmaceutical industry increasingly prioritises sustainability, Lannett's future climate commitments will be crucial for aligning with industry standards and expectations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Lannett Company, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Lannett Company, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Lannett Company, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project